Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02530619
Title Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Northwestern University
Indications

myelofibrosis

acute megakaryocytic leukemia

Therapies

Alisertib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida 33136 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field